Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Intercept Pharmaceuticals Company Profile (NASDAQ:ICPT)

Consensus Ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 11 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $447.08 (188.68% upside)

Analysts' Ratings History for Intercept Pharmaceuticals (NASDAQ:ICPT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/11/2014NomuraReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
11/10/2014FBR Capital MarketsLower Price TargetUnderperform$172.00 -> $125.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2014Leerink SwannDowngradeOutperform -> Market Perform$445.00 -> $191.00ViewTweet This Rating  Share This Rating on StockTwits
11/4/2014Summer StreetReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
10/23/2014NomuraReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
10/7/2014JMP SecuritiesInitiated CoverageOutperform$500.00ViewTweet This Rating  Share This Rating on StockTwits
9/5/2014Cowen and CompanyInitiated CoverageOutperform$420.00ViewTweet This Rating  Share This Rating on StockTwits
8/15/2014FBR Capital MarketsInitiated CoverageUnderperform$172.00ViewTweet This Rating  Share This Rating on StockTwits
8/14/2014TheStreetUpgradeHoldViewTweet This Rating  Share This Rating on StockTwits
8/12/2014NomuraUpgradePositive$323.00 -> $456.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2014RBC CapitalBoost Price TargetOutperform$425.00 -> $500.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2014Leerink SwannUpgradeMarket Perform -> Outperform$270.00 -> $445.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2014Deutsche BankUpgradeOutperform$395.00 -> $500.00ViewTweet This Rating  Share This Rating on StockTwits
7/29/2014NomuraUpgradeNeutral -> Buy$323.00ViewTweet This Rating  Share This Rating on StockTwits
7/14/2014Deutsche BankInitiated CoverageBuy$395.00ViewTweet This Rating  Share This Rating on StockTwits
7/2/2014Goldman SachsInitiated CoverageNeutral$265.00ViewTweet This Rating  Share This Rating on StockTwits
6/30/2014RBC CapitalInitiated CoverageOutperform$425.00ViewTweet This Rating  Share This Rating on StockTwits
6/27/2014Summer StreetReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
6/26/2014Leerink SwannInitiated CoverageMarket Perform$270.00ViewTweet This Rating  Share This Rating on StockTwits
6/26/2014NomuraInitiated CoverageNeutral$294.00ViewTweet This Rating  Share This Rating on StockTwits
5/15/2014Summer StreetInitiated CoverageBuy$650.00ViewTweet This Rating  Share This Rating on StockTwits
5/8/2014OppenheimerLower Price TargetOutperform$525.00 -> $499.00ViewTweet This Rating  Share This Rating on StockTwits
4/14/2014Needham & Company LLCReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
3/18/2014Needham & Company LLCBoost Price TargetBuy$320.00 -> $500.00ViewTweet This Rating  Share This Rating on StockTwits
3/17/2014Needham & Company LLCReiterated RatingBuy$320.00 -> $500.00ViewTweet This Rating  Share This Rating on StockTwits
3/14/2014OppenheimerBoost Price TargetOutperform$360.00 -> $525.00ViewTweet This Rating  Share This Rating on StockTwits
3/14/2014Citigroup Inc.Boost Price TargetBuy$600.00 -> $700.00ViewTweet This Rating  Share This Rating on StockTwits
2/10/2014WedbushBoost Price Target$449.00 -> $493.00ViewTweet This Rating  Share This Rating on StockTwits
1/22/2014WedbushBoost Price TargetFair Value$72.00 -> $449.00ViewTweet This Rating  Share This Rating on StockTwits
1/13/2014BMO Capital MarketsReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
1/13/2014Citigroup Inc.Boost Price Target$600.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014Janney Montgomery ScottBoost Price Target$300.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014Needham & Company LLCBoost Price TargetBuy$55.00 -> $320.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014OppenheimerBoost Price TargetOutperform$94.00 -> $360.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014Citigroup Inc.Reiterated RatingBuy$60.00 -> $400.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014Bank of AmericaBoost Price TargetBuy$81.00 -> $872.00ViewTweet This Rating  Share This Rating on StockTwits
1/9/2014BMO Capital MarketsBoost Price Target$270.00 -> $375.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2013OppenheimerBoost Price TargetOutperform$64.00 -> $94.00ViewTweet This Rating  Share This Rating on StockTwits
9/20/2013BMO Capital MarketsBoost Price TargetOutperform$62.00 -> $107.00ViewTweet This Rating  Share This Rating on StockTwits
8/14/2013BMO Capital MarketsReiterated RatingOutperform$44.00 -> $62.00ViewTweet This Rating  Share This Rating on StockTwits
8/13/2013Needham & Company LLCBoost Price TargetBuy$40.00 -> $55.00ViewTweet This Rating  Share This Rating on StockTwits
8/13/2013WedbushReiterated RatingOutperform$65.00 -> $67.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2013Citigroup Inc.Initiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
7/11/2013OppenheimerBoost Price TargetOutperform$60.00 -> $64.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2013OppenheimerInitiated CoverageOutperform$60.00ViewTweet This Rating  Share This Rating on StockTwits
5/21/2013WedbushBoost Price Target$56.00 -> $65.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013WedbushReiterated RatingOutperform$46.00 -> $56.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2013Janney Montgomery ScottInitiated CoverageBuy$48.00ViewTweet This Rating  Share This Rating on StockTwits
1/16/2013WedbushBoost Price TargetOutperform$25.00 -> $46.00ViewTweet This Rating  Share This Rating on StockTwits
1/4/2013Needham & Company LLCBoost Price TargetBuy$24.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/23/2012 forward)